Bioqual ROE 2012-2025 | BIOQ
Current and historical return on equity (ROE) values for Bioqual (BIOQ) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Bioqual ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-11-30 | $0.00B | $0.04B | 2.78% |
| 2025-08-31 | $0.00B | $0.04B | 0.00% |
| 2025-05-31 | $0.00B | $0.04B | -2.78% |
| 2025-02-28 | $0.00B | $0.04B | -5.48% |
| 2024-11-30 | $0.00B | $0.04B | -8.05% |
| 2024-08-31 | $0.00B | $0.04B | -5.23% |
| 2024-05-31 | $0.00B | $0.04B | 0.00% |
| 2024-02-29 | $0.00B | $0.04B | 0.00% |
| 2023-11-30 | $0.00B | $0.04B | -2.60% |
| 2023-08-31 | $0.00B | $0.04B | 0.00% |
| 2023-05-31 | $0.00B | $0.04B | 0.00% |
| 2023-02-28 | $0.00B | $0.04B | 7.79% |
| 2022-11-30 | $0.01B | $0.04B | 13.16% |
| 2022-08-31 | $0.01B | $0.04B | 13.51% |
| 2022-05-31 | $0.01B | $0.04B | 13.89% |
| 2022-02-28 | $0.01B | $0.04B | 14.29% |
| 2021-11-30 | $0.01B | $0.03B | 14.81% |
| 2021-08-31 | $0.01B | $0.03B | 15.38% |
| 2021-05-31 | $0.01B | $0.03B | 19.20% |
| 2021-02-28 | $0.01B | $0.03B | 16.81% |
| 2020-11-30 | $0.01B | $0.03B | 17.39% |
| 2020-08-31 | $0.01B | $0.03B | 18.02% |
| 2020-05-31 | $0.00B | $0.02B | 19.75% |
| 2020-02-29 | $0.00B | $0.02B | 20.51% |
| 2019-11-30 | $0.00B | $0.01B | 23.53% |
| 2019-08-31 | $0.00B | $0.01B | 48.00% |
| 2019-05-31 | $0.00B | $0.01B | 48.00% |
| 2019-02-28 | $0.00B | $0.01B | 54.55% |
| 2018-11-30 | $0.00B | $0.01B | 72.73% |
| 2018-08-31 | $0.00B | $0.01B | 72.73% |
| 2018-05-31 | $0.00B | $0.01B | 72.73% |
| 2018-02-28 | $0.00B | 0 | 0.00% |
| 2017-11-30 | $0.00B | 0 | 0.00% |
| 2017-08-31 | $0.00B | 0 | 0.00% |
| 2017-05-31 | $0.00B | 0 | 0.00% |
| 2017-02-28 | $0.00B | 0 | 0.00% |
| 2016-11-30 | $0.00B | 0 | 0.00% |
| 2016-08-31 | $0.00B | 0 | 0.00% |
| 2016-05-31 | $0.00B | 0 | 0.00% |
| 2016-02-29 | $0.00B | 0 | 0.00% |
| 2015-11-30 | $0.00B | 0 | 0.00% |
| 2015-08-31 | $0.00B | 0 | 0.00% |
| 2015-05-31 | $0.00B | 0 | 0.00% |
| 2015-02-28 | $0.00B | 0 | 0.00% |
| 2014-08-31 | $0.00B | 0 | 0.00% |
| 2014-05-31 | $0.00B | 0 | 0.00% |
| 2013-11-30 | $0.00B | 0 | 0.00% |
| 2013-08-31 | $0.00B | 0 | 0.00% |
| 2013-05-31 | $0.00B | 0 | 0.00% |
| 2012-05-31 | $0.00B | 0 | 0.00% |
| 2012-02-29 | $0.00B | 0 | 0.00% |
| 2011-11-30 | $0.00B | 0 | 0.00% |
| 2011-08-31 | $0.00B | 0 | 0.00% |
| 2011-05-31 | $0.00B | 0 | 0.00% |
| 2011-02-28 | $0.00B | 0 | 0.00% |
| 2010-11-30 | $0.00B | 0 | 0.00% |
| 2010-08-31 | $0.00B | 0 | 0.00% |
| 2010-05-31 | $0.00B | 0 | 0.00% |
| 2009-11-30 | $0.00B | 0 | 0.00% |
| 2009-08-31 | $0.00B | 0 | 0.00% |
| 2008-05-31 | $0.00B | $0.00B | 0.00% |
| 2002-05-31 | $0.00B | $0.00B | 0.00% |
| 2002-02-28 | $0.00B | $0.00B | 0.00% |
| 2001-11-30 | $0.00B | $0.00B | 0.00% |
| 2001-08-31 | $0.00B | $0.00B | 0.00% |
| 2001-05-31 | $0.00B | $0.00B | 0.00% |
| 2001-02-28 | $0.00B | $0.00B | 0.00% |
| 2000-11-30 | $0.00B | $0.00B | 0.00% |
| 2000-08-31 | $0.00B | $0.00B | 0.00% |
| 2000-05-31 | $0.00B | $0.00B | 0.00% |
| 2000-02-29 | $0.00B | $0.00B | 0.00% |
| 1999-11-30 | $0.00B | $0.00B | 0.00% |
| 1999-08-31 | $0.00B | $0.00B | 0.00% |
| 1999-05-31 | $0.00B | $0.00B | 0.00% |
| 1999-02-28 | $0.00B | $0.00B | 0.00% |
| 1998-11-30 | $0.01B | $0.00B | 366.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.034B | $0.049B |
| BIOQUAL, Inc., formerly Diagnon Corporation, develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $34.042B | 17.17 |
| Quest Diagnostics (DGX) | United States | $23.013B | 21.00 |
| Elanco Animal Health (ELAN) | United States | $12.486B | 26.18 |
| Encompass Health (EHC) | United States | $11.082B | 20.17 |
| DaVita (DVA) | United States | $9.950B | 13.72 |
| Chemed (CHE) | United States | $6.703B | 23.54 |
| Option Care Health (OPCH) | United States | $5.622B | 23.93 |
| RadNet (RDNT) | United States | $5.365B | 183.00 |
| LifeStance Health (LFST) | United States | $2.735B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.103B | 21.72 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.657B | 20.87 |
| U.S Physical Therapy (USPH) | United States | $1.322B | 33.44 |
| Pennant (PNTG) | United States | $1.106B | 36.75 |
| Astrana Health (ASTH) | United States | $1.057B | 98.84 |
| Daxor (DXR) | United States | $0.062B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.038B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |